These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3891255)

  • 1. Vaccine development for the control of cholera and related toxin-induced diarrhoeal diseases.
    Holmgren J; Svennerholm AM
    Ciba Found Symp; 1985; 112():242-70. PubMed ID: 3891255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New knowledge on pathogenesis of bacterial enteric infections as applied to vaccine development.
    Levine MM; Kaper JB; Black RE; Clements ML
    Microbiol Rev; 1983 Dec; 47(4):510-50. PubMed ID: 6363898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of efficacy of CVD 103-HgR live oral cholera vaccine against all-cause travellers' diarrhoea in a randomised, double-blind, placebo-controlled study.
    Leyten EM; Soonawala D; Schultsz C; Herzog C; Ligthelm RJ; Wijnands S; Visser LG
    Vaccine; 2005 Oct; 23(43):5120-6. PubMed ID: 15982790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitoxic immunity in cholera and enterotoxigenic Escherichia coli (ETEC) diarrhea.
    DuPont HL; Evans DG; Evans DJ; Satterwhite TK
    Pharmacol Ther; 1981; 13(2):249-55. PubMed ID: 7025036
    [No Abstract]   [Full Text] [Related]  

  • 5. Strategies for the induction of immune responses at mucosal surfaces making use of cholera toxin B subunit as immunogen, carrier, and adjuvant.
    Holmgren J; Czerkinsky C; Lycke N; Svennerholm AM
    Am J Trop Med Hyg; 1994; 50(5 Suppl):42-54. PubMed ID: 8203723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholera as a model for research on mucosal immunity and development of oral vaccines.
    Holmgren J; Czerkinsky C
    Curr Opin Immunol; 1992 Aug; 4(4):387-91. PubMed ID: 1388838
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the current status of enteric vaccines.
    Levine MM; Noriega F
    P N G Med J; 1995 Dec; 38(4):325-31. PubMed ID: 9522876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Introductory evaluation of an oral, killed whole cell enterotoxigenic Escherichia coli plus cholera toxin B subunit vaccine in Egyptian infants.
    Savarino SJ; Hall ER; Bassily S; Wierzba TF; Youssef FG; Peruski LF; Abu-Elyazeed R; Rao M; Francis WM; El Mohamady H; Safwat M; Naficy AB; Svennerholm AM; Jertborn M; Lee YJ; Clemens JD;
    Pediatr Infect Dis J; 2002 Apr; 21(4):322-30. PubMed ID: 12075764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New vaccines against bacterial enteric infections.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 70():149-56. PubMed ID: 2287897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral cholera vaccines: use in clinical practice.
    Hill DR; Ford L; Lalloo DG
    Lancet Infect Dis; 2006 Jun; 6(6):361-73. PubMed ID: 16728322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a vaccine against experimental cholera and Escherichia coli diarrheal disease.
    Rappaport RS; Bonde G
    Infect Immun; 1981 May; 32(2):534-41. PubMed ID: 7019073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of oral vaccines against cholera and enterotoxinogenic Escherichia coli diarrhea.
    Holmgren J; Svennerholm AM
    Scand J Infect Dis Suppl; 1990; 76():47-53. PubMed ID: 2102020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New cholera vaccines.
    Holmgren J; Clemens J; Sack DA; Svennerholm AM
    Vaccine; 1989 Apr; 7(2):94-6. PubMed ID: 2665353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial enteric infections and vaccine development.
    Holmgren J; Svennerholm AM
    Gastroenterol Clin North Am; 1992 Jun; 21(2):283-302. PubMed ID: 1512046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of oral vaccines against enterotoxinogenic Escherichia coli diarrhoea.
    Svennerholm AM; Holmgren J; Sack DA
    Vaccine; 1989 Jun; 7(3):196-8. PubMed ID: 2675484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An oral B subunit: whole cell vaccine against cholera.
    Holmgren J; Svennerholm AM; Jertborn M; Clemens J; Sack DA; Salenstedt R; Wigzell H
    Vaccine; 1992; 10(13):911-4. PubMed ID: 1471411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunization of a live attenuated Escherichia coli strain expressing a holotoxin-structured adhesin-toxoid fusion (1FaeG-FedF-LTA₂:5LTB) protected young pigs against enterotoxigenic E. coli (ETEC) infection.
    Ruan X; Zhang W
    Vaccine; 2013 Mar; 31(11):1458-63. PubMed ID: 23375979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of vaccines against cholera and diarrhoea due to enterotoxigenic Escherichia coli: memorandum from a WHO meeting.
    Bull World Health Organ; 1990; 68(3):303-12. PubMed ID: 2203550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination with Dukoral against travelers' diarrhea (ETEC) and cholera.
    Jelinek T; Kollaritsch H
    Expert Rev Vaccines; 2008 Jul; 7(5):561-7. PubMed ID: 18564011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of fecal-orally transmitted diseases in travelers through an oral anticholeric vaccine (WC/rBS).
    Gabutti G; Aquilina M; Cova M; Giuffrida S; Lizioli A; Protano D; Scrivano F; Tomasi A; Cucchi A; Cavallaro A;
    J Prev Med Hyg; 2012 Dec; 53(4):199-203. PubMed ID: 23469588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.